Janssen AI Investigational Site

Washington D.C., District of Columbia 20057

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease — Completed
• AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease — Stopped early